a year ago
BHVN
AnalystsChristopher RaymondChristopher Raymond's Stock Forecasts
AnalystsChristopher Raymond
Analyst Ranking
Bottom 15%
#4348 out of 5087 analysts
Average Return
-0.27%
Win Rate
44%48 out of 108
Risk vs Reward
Poor
Good
Christopher Raymond's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Monopar TherapeuticsMNPR | +239.88% | $25.35 | $86.16 | 2025-01-10 - 2025-10-31 | Strong Buy |
Inovio Pharmaceuticals IncINO | +196.98% | $35.76 | $106.20 | 2020-01-03 - 2020-12-31 | Strong Buy |
Vectivbio Holding AgVECT | +186.96% | $5.75 | $16.50 | 2022-07-01 - 2023-05-23 | Strong Buy |
Biohaven LtdBHVN | +149.77% | $11.09 | $27.70 | 2022-10-12 - 2023-10-11 | Strong Buy |
Ardelyx IncARDX | +134.30% | $1.72 | $4.03 | 2022-11-17 - 2023-11-16 | Strong Buy |
Christopher Raymond Analyst Color
Get additional color on Christopher Raymond's coverage of popular stocks
a year ago
BMRN
a year ago
REGN
a year ago
ABBV
a year ago
REGN
a year ago
ABBV
2 years ago
BHVN
2 years ago
DCPH
2 years ago
ABBV
2 years ago
BIIB
3 years ago
BIIB
3 years ago
ABBV
3 years ago
BMRN
Christopher Raymond's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Taysha Gene Therapies IncTSHA | 3 | Strong Buy | $13.00 | +162.10% | Initiates Coverage On | 14 days ago |
Meiragtx Holdings PLCMGTX | 2 | Strong Buy | $29.00 | +219.38% | Initiates Coverage On | 14 days ago |
Abbvie IncABBV | 13 | Strong Buy | $284.00 | +30.25% | Maintains | 25 days ago |
Ardelyx IncARDX | 8 | Hold | $9.00 | +48.51% | Maintains | 3 months ago |
Abivax SaABVX | 2 | Strong Buy | $70.00 | -31.65% | Maintains | 3 months ago |
Biogen IncBIIB | 12 | Hold | $115.00 | -25.46% | Maintains | 6 months ago |
Alx Oncology Holdings IncALXO | 6 | Strong Buy | $9.00 | +484.42% | Maintains | 8 months ago |
Biomarin Pharmaceutical IncBMRN | 9 | Strong Buy | $126.00 | +135.21% | Maintains | 8 months ago |
Q32 Bio IncQTTB | 3 | Hold | $4.00 | +42.35% | Downgrades | 9 months ago |
Blueprint Medicines CorpBPMC | 3 | Hold | $119.00 | -8.08% | Maintains | 9 months ago |
Vertex Pharmaceuticals IncVRTX | 7 | Strong Buy | $533.00 | +25.24% | Maintains | 9 months ago |
Regeneron Pharmaceuticals IncREGN | 7 | Strong Buy | $1,013.00 | +55.42% | Maintains | 9 months ago |
Ultragenyx Pharmaceutical IncRARE | 5 | Strong Buy | $140.00 | +304.62% | Maintains | 10 months ago |
Inozyme Pharma IncINZY | 1 | Strong Buy | $30.00 | +650.00% | Maintains | 10 months ago |
Monopar TherapeuticsMNPR | 1 | Strong Buy | $72.00 | -16.43% | Initiates Coverage On | 10 months ago |
Aclaris Therapeutics IncACRS | 2 | Strong Buy | $13.00 | +415.87% | Upgrades | a year ago |
Karyopharm Therapeutics IncKPTI | 4 | Strong Buy | $75.00 | +1,193.10% | Maintains | a year ago |
Biohaven LtdBHVN | 4 | Strong Buy | $76.00 | N/A | Maintains | a year ago |
Io Biotech IncIOBT | 2 | Strong Buy | $10.00 | N/A | Maintains | a year ago |
Tyra Biosciences IncTYRA | 1 | Strong Buy | $33.00 | N/A | Initiates Coverage On | a year ago |
Kalaris Therapeutics IncKLRS | 2 | Hold | $34.50 | N/A | Downgrades | 2 years ago |
Deciphera Pharmaceuticals IncDCPH | 1 | Strong Buy | $23.00 | N/A | Upgrades | 2 years ago |
Kinnate Biopharma IncKNTE | 2 | Hold | $4.00 | N/A | Downgrades | 2 years ago |
Cogent Biosciences IncCOGT | 1 | Strong Buy | $22.00 | N/A | Maintains | 2 years ago |
Akebia Therapeutics IncAKBA | 2 | Strong Buy | $4.00 | N/A | Upgrades | 2 years ago |
Vectivbio Holding AgVECT | 2 | Hold | $17.00 | N/A | Downgrades | 2 years ago |
Amgen IncAMGN | 9 | Strong Buy | $288.00 | N/A | Maintains | 3 years ago |
Agios Pharmaceuticals IncAGIO | 1 | Strong Buy | $41.00 | N/A | Initiates Coverage On | 3 years ago |
Otonomy IncOTIC | 1 | Hold | $0.50 | N/A | Downgrades | 3 years ago |
Biohaven Pharmaceutical Holding Co LtdBHVN1 | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Aptinyx IncAPTX | 3 | Hold | $2.00 | N/A | Downgrades | 3 years ago |
Oncorus IncONCR | 2 | Strong Buy | $12.00 | N/A | Maintains | 3 years ago |
Calcimedica IncCALC | 4 | Hold | $2.00 | N/A | Maintains | 3 years ago |
Acceleron Pharma IncXLRN | 2 | Hold | $180.00 | N/A | Downgrades | 4 years ago |
Nuvalent IncNUVL | 1 | Strong Buy | $40.00 | N/A | Initiates Coverage On | 4 years ago |
Solid Biosciences IncSLDB | 1 | Hold | $90.00 | N/A | Initiates Coverage On | 4 years ago |
Amag Pharmaceuticals IncAMAG | 2 | Hold | N/A | N/A | Upgrades | 5 years ago |
Aimmune Therapeutics IncAIMT | 1 | Hold | $34.50 | N/A | Downgrades | 5 years ago |
Prevail Therapeutics IncPRVL | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 6 years ago |
Inovio Pharmaceuticals IncINO | 2 | Hold | $96.00 | N/A | Downgrades | 6 years ago |
Alexion Pharmaceuticals IncALXN | 1 | Strong Buy | $170.00 | N/A | Assumes | 8 years ago |
Celgene CorpCELG | 1 | Hold | $133.00 | N/A | Assumes | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.